Edition:
India

Obseva SA (OBSV.OQ)

OBSV.OQ on NASDAQ Stock Exchange Global Select Market

9.75USD
19 Jan 2018
Change (% chg)

$0.05 (+0.52%)
Prev Close
$9.70
Open
$9.75
Day's High
$9.75
Day's Low
$9.73
Volume
119
Avg. Vol
9,084
52-wk High
$14.18
52-wk Low
$5.02

Latest Key Developments (Source: Significant Developments)

Obseva Initiates Phase 2A Clinical Trial Of Obe022 In Preterm Labor
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Obseva Sa ::OBSEVA INITIATES PROLONG, THE PHASE 2A CLINICAL TRIAL OF OBE022 IN PRETERM LABOR.OBSEVA SA - ‍OBSEVA EXPECTS TO ANNOUNCE PRELIMINARY RESULTS FROM 60 PATIENTS IN PART B OF PROLONG TRIAL IN LATE 2018​.  Full Article

ObsEva SA files for resale of up to 7.5 million common shares‍​
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Obseva Sa :ObsEva SA - files for resale of up to 7.5 million common shares‍​ of co by the selling shareholders - SEC filing.  Full Article

ObsEva SA announces $60 mln private placement with existing and new investors
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - ObsEva SA : :ObsEva SA announces $60.0 million private placement with existing and new investors.ObsEva SA - ‍common shares in offering are priced at $8.00 per share.ObsEva SA - ‍net proceeds from offering are expected to be used to fund research,development of lead compound OBE2109, among others​.  Full Article

ObsEva Q2 loss per share $0.61
Wednesday, 16 Aug 2017 

Aug 15 (Reuters) - ObsEva SA :ObsEva reports second quarter 2017 financial results and provides business update.Q2 loss per share $0.61.Q2 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S.  Full Article

ObsEva SA announces pricing of initial public offering
Thursday, 26 Jan 2017 

ObsEva SA : Announces pricing of initial public offering .Announced pricing of its initial public offering of 6.45 million common shares at initial public offering price of $15 per share.  Full Article

BRIEF-Obseva Initiates Phase 2A Clinical Trial Of Obe022 In Preterm Labor

* OBSEVA INITIATES PROLONG, THE PHASE 2A CLINICAL TRIAL OF OBE022 IN PRETERM LABOR